248
Participants
Start Date
November 30, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
August 31, 2013
Absolute risk reduction
Patients receive effectiveness information concerning cholesterol lowering therapy by means of absolute risk reduction
Prolongation of life
Patients receive effectiveness information concerning cholesterol lowering therapy by means of prolongation of life/life extension.
Collaborators (1)
Danish Heart Foundation
OTHER
University of Southern Denmark
OTHER